UnitedHealth Group (NYSE:UNH) Shares Climb 2% After Analyst Upgrade

Key Points

• UnitedHealth shares rose 2% after Mizuho raised its price target from $493 to $500 and maintained an “outperform” rating.
• Wall Street sentiment remains broadly positive, with 20 analysts rating the stock a Buy and eight issuing Holds; the consensus rating is “Moderate Buy” with a $463.80 price target.
• UnitedHealth recently beat quarterly earnings expectations, reporting $4.69 in adjusted EPS versus $4.14 expected, while institutional investors own approximately 87.86% of the company.

Shares of UnitedHealth Group Incorporated (NYSE:UNH - Get Free Report) rose 2% on Thursday after Mizuho raised their price target on the stock from $493.00 to $500.00. Mizuho currently has an outperform rating on the stock. UnitedHealth Group traded as high as $426.55 and last traded at $425.2860. 5,412,030 shares changed hands during trading, a decline of 26% from the average session volume of 7,356,971 shares. The stock had previously closed at $417.00.

A number of other analysts have also recently weighed in on the company. HSBC increased their price objective on UnitedHealth Group from $300.00 to $380.00 and gave the stock a "hold" rating in a research report on Monday, July 6th. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $468.00 to $529.00 and gave the company an "overweight" rating in a report on Friday, July 17th. Piper Sandler increased their price target on shares of UnitedHealth Group from $502.00 to $504.00 and gave the stock an "overweight" rating in a report on Wednesday, October 14th. Wells Fargo & Company boosted their target price on UnitedHealth Group from $397.00 to $485.00 and gave the stock an "overweight" rating in a research report on Monday, July 13th. Finally, HC Wainwright set a $500.00 target price on UnitedHealth Group in a research note on Friday, October 16th. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus price target of $463.80.

Insider Activity at UnitedHealth Group

In related news, CEO Patrick Conway sold 1,169 shares of the company's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the sale, the chief executive officer owned 15,328 shares in the company, valued at $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.19% of the stock is owned by company insiders.

Key UnitedHealth Group News

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Strong third-quarter results support the recovery. Adjusted earnings per share rose approximately 61%, while the medical care ratio improved to 88.4%, indicating that UnitedHealth retained more premium revenue after covering medical costs. Management also raised its full-year outlook, reinforcing expectations for better profitability. UnitedHealth's Earnings Jumped 60%. Is the Comeback Stock a Buy, Sell, or Hold?
• Positive Sentiment: Mizuho raised its price target. The firm increased its target from $493 to $500 and maintained an “outperform” rating, signaling confidence that earnings improvement and the company’s turnaround can continue. Mizuho UnitedHealth rating
• Positive Sentiment: Valuation and operating leverage are attracting investors. Zacks characterized UNH as a strong value stock, while a separate analysis argued that operating leverage could drive additional earnings growth. Increased investor attention and generally bullish Wall Street recommendations are also supporting sentiment. Why UnitedHealth Is a Strong Value Stock
• Neutral Sentiment: Optum provides earnings diversification, but not complete protection. Optum contributed roughly half of UnitedHealth’s reported second-quarter operating earnings, although medical inflation and Medicare funding pressure affect both its insurance and healthcare-services businesses. Does Optum Truly Diversify Its Earnings Risk?
• Negative Sentiment: Higher Medicare costs could pressure demand and political sentiment. UnitedHealth is expected to raise 2027 Medicare costs for seniors, while older Americans are already facing higher healthcare expenses. Increased premiums and prescription-drug costs could create affordability concerns and regulatory scrutiny. UnitedHealth Will Raise 2027 Medicare Costs
• Negative Sentiment: Healthcare-sector weakness remains a near-term headwind. Healthcare stocks moved lower late Wednesday, suggesting that some of UNH’s gains may remain vulnerable to sector-wide trading pressure. Healthcare Stocks Softer Late Afternoon

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. General Partner Inc. purchased a new stake in UnitedHealth Group during the third quarter valued at about $512,000. PBCay One RSC Ltd purchased a new position in shares of UnitedHealth Group in the first quarter worth about $14,343,000. Lee Johnson Capital Management LLC bought a new stake in shares of UnitedHealth Group in the 2nd quarter valued at about $6,180,000. Kinsale Capital Group Inc. boosted its holdings in UnitedHealth Group by 13.4% during the 2nd quarter. Kinsale Capital Group Inc. now owns 38,510 shares of the healthcare conglomerate's stock valued at $16,006,000 after acquiring an additional 4,557 shares during the period. Finally, Fideuram Intesa Sanpaolo Private Banking S.P.A. boosted its holdings in UnitedHealth Group by 1,287.2% during the 1st quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A. now owns 60,022 shares of the healthcare conglomerate's stock valued at $16,241,000 after acquiring an additional 55,695 shares during the period. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Trading Up 2.0%

The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.74. The firm has a 50-day moving average of $387.63 and a 200-day moving average of $388.48. The firm has a market capitalization of $381.73 billion, a P/E ratio of 24.29, a price-to-earnings-growth ratio of 1.51 and a beta of 0.60.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating analysts' consensus estimates of $4.14 by $0.55. UnitedHealth Group had a return on equity of 17.95% and a net margin of 3.53%. The firm had revenue of $112.70 billion during the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the prior year, the firm posted $2.59 earnings per share. The business's quarterly revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities research analysts anticipate that UnitedHealth Group Incorporated will post 20.64 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th were given a $2.32 dividend. The ex-dividend date was Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a dividend yield of 2.2%. UnitedHealth Group's payout ratio is presently 53.00%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated NYSE: UNH is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.